Fexapotide

Fexapotide (NX-1207 free acid) selectively induces apoptosis to effectively reduce prostate volume at the cellular level and is applicable in the research of lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH) [1][2][3].

[C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H]([C@H](CC)C)N)=O)CC(O)=O)=O)CCC(N)=O)=O)CCC(N)=O)=O)C(C)C)=O)CC(C)C)=O)CO)=O)CCCNC(=N)N)=O)[C@H](CC)C)=O)(C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CC(C)C)C(O)=O)=O)CS)=O)CCCNC(=N)N)=O)CCCCN)=O)[C@H](CC)C)=O)CCC(O)=O)=O)CC(C)C)=O)CCCCN